Add BrightSurf on Google Email

The Lancet


Nonhospitalized patients with active inflammatory bowel disease are 16 times more likely to suffer a blood clot than the general population

Patients with active inflammatory bowel disease are at a significantly increased risk of developing venous thromboembolism, especially when ambulatory. The study found that non-hospitalized patients with active IBD have a relative risk of 16 times higher than the general population, highlighting the need for prophylaxis strategies.

SourceThe Lancet_DELETED·JournalThe Lancet·DateFeb 8, 2010

A lower overall radiotherapy dose given in fewer, larger daily doses can result in better quality of life for patients with breast cancer

A study published in The Lancet Oncology found that hypofractionated radiotherapy schedules do not increase adverse symptoms or worsen body image compared to the international standard treatment. Patients reported moderate or striking concerns about body image, but these did not differ between radiotherapy schedules.

SourceThe Lancet_DELETED·JournalThe Lancet Oncology·DateFeb 7, 2010

Rapid breathing, parental concern, and doctor's instinct among the red flags warning of serious infection in children in developed countries

A systematic review highlights clinical features that confirm or exclude the possibility of serious infection in children presenting to general practice. Clinical features like cyanosis, poor peripheral perfusion, and petechial rash are deemed red flags, while parental concern and doctor's instinct are strong indicators.

SourceThe Lancet_DELETED·JournalThe Lancet·DateFeb 2, 2010

No difference in survival between leukaemia patients 10 years after undergoing stem-cell or marrow transplant

Patients who underwent peripheral blood stem cell transplantation (PBSC) had similar overall survival rates as those given bone marrow transplants, with no significant differences in mortality or late effects. However, subgroup analyses revealed improved leukaemia-free survival and overall survival for patients with acute leukaemias

SourceThe Lancet_DELETED·JournalThe Lancet Oncology·DateJan 31, 2010

Herceptin improves event-free survival in women with HER2-positive locally advanced or inflammatory breast cancer (NOAH trial)

Researchers found that Herceptin significantly improved event-free survival in patients with HER2-positive locally advanced or inflammatory breast cancer, with a 3-year event-free survival rate of 71% compared to 56%. The treatment was well-tolerated, with only two patients experiencing symptomatic cardiac failure.

SourceThe Lancet_DELETED·JournalThe Lancet·DateJan 28, 2010

Proportion of non-battle-related disorders causing medical evaucation from front line is increasing and must be addressed

A study published in The Lancet found that non-battle-related disorders, such as musculoskeletal and connective tissue disorders, are the leading cause of medical evacuation from the front line. The study also identified factors associated with return to duty, including senior officer status and non-battle related injuries.

SourceThe Lancet_DELETED·JournalThe Lancet·DateJan 21, 2010

Blood fats reduced in HIV patients who switch from lopinavir-ritonavir to raltegravir, but viral supression rate lower in raltegravir patients (SWITCHMRK trials)

A recent study found that HIV patients who switch from lopinavir-ritonavir to raltegravir experience a reduction in blood fat levels, but the rate of viral suppression is lower in the raltegravir group. The results suggest that clinicians need to consider individual patient factors when making treatment decisions.

SourceThe Lancet_DELETED·JournalThe Lancet·DateJan 12, 2010

Imaging can differentiate different forms of Parkinsonism

A study using positron emission tomography (PET) brain scans identified different forms of Parkinsonism with high accuracy. The research found that image-based classification had excellent specificity and positive predictive value for idiopathic Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy.

SourceThe Lancet_DELETED·JournalThe Lancet Neurology·DateJan 10, 2010

Got a pet tarantula? Then wear eye protection

A 29-year-old man experienced symptoms after a tarantula released 'a mist of hairs' into the air, which got stuck in his eyes. He was treated with topical steroids and made a full recovery. The case highlights the importance of proper eye protection when handling tarantulas.

SourceThe Lancet_DELETED·JournalThe Lancet·DateDec 31, 2009

Catheter ablation prior to defibrillator shock reduces risk of recurrence of life threatening rapid heartbeat in patients with stable ventricular tachycardia (VTACH study)

A randomized controlled trial shows that catheter ablation before ICD implantation reduces VT recurrence at two years, with a 40% lower risk of repeat VT or VF. Prophylactic catheter ablation may be considered for patients with stable VT and reduced left-ventricular function.

SourceThe Lancet_DELETED·JournalThe Lancet·DateDec 31, 2009

An unusual case of variant CJD

A 30-year-old man died of variant Creutzfeldt-Jakob disease (vCJD) with a unique genetic profile, highlighting potential cases with long incubation periods. His heterozygous PRNP gene may indicate silently infected individuals, posing concerns for public health.

SourceThe Lancet_DELETED·JournalThe Lancet·DateDec 17, 2009

Antiretroviral therapy can be delivered safely in Africa without routine laboratory monitoring for toxic effects

Researchers found that first-line ART can be delivered safely without routine biochemistry and haematology monitoring, but CD4-cell count monitoring has a small benefit in disease progression and mortality. The trial suggests that monitoring should start from the second year of ART to guide the switch to second-line treatment.

SourceThe Lancet_DELETED·JournalThe Lancet·DateDec 8, 2009

Medroxyprogesterone best treatment for reducing hot flushes in men undergoing hormone therapy for prostate cancer

A randomised trial found that medroxyprogesterone acetate is significantly more effective than venlafaxine at reducing hot flushes in men treated with androgen suppression therapy. Cyproterone acetate was also effective, but medroxyprogesterone is recommended as the standard treatment due to its fewer side effects.

SourceThe Lancet_DELETED·JournalThe Lancet Oncology·DateDec 6, 2009

Ending intimate partner violence

The UK Government's new strategy focuses on preventing intimate partner violence through education and community programs. The plan includes a national communications program and adding gender equality to the school curriculum.

SourceThe Lancet_DELETED·JournalThe Lancet·DateDec 3, 2009

New antibiotics urgently needed

A global drive is necessary to develop new antibiotics, with only a single new antibacterial approved in the USA since 2006. The EU report also shows limited progress, with just five new drugs reaching phase 3 clinical trials within the next 10 years.

SourceThe Lancet_DELETED·JournalThe Lancet·DateDec 3, 2009